Aster DM Healthcare and Cayman Islands Government today announced an agreement for making the Cayman Islands as Aster’s clinical excellence hub for the Western hemisphere, serving North America, the Caribbean region, Canada, Latin & South America. 

Oil India Limited, the second-largest national exploration & production company announced on Tuesday that it has signed a memorandum of understanding (MoU) with Assam Hydrocarbon & Energy Company Limited in Guwahati, India.  

Zensar Technologies announced that it has been selected by NFU Mutual, the UK’s leading rural insurer, to form a new strategic technology and digital relationship to support multiple technologies that underpin a number of the company’s key business systems. 

Hindustan Foods Limited (HFL) has announced that it will be undertaking a capital expenditure worth Rs 125 crore in the Northern region of India through its wholly-owned subsidiary, HFL Consumer Products Private Limited. 

The civil engineering company will construct an elevated viaduct of 11.6 km from Kadarshani Nal (Gujarat) to Dream City Dead End for Surat Metro Rail Project Phase-1.  The project is worth Rs 779.73 crore with a construction period of 30 months. 

Birlasoft has multiple verticals including energy, manufacturing, banking, financial services & insurance (BFSI). The company also provides digital transformation and integrated solutions to enterprises. The contribution from these verticals is divided and is not dependent on one particular industry thereby, making it a diversified portfolio.

The market opened in red on December 22, 2020, overall volumes in futures & options currently stand at 3,78,82,868 contracts with a turnover of Rs. 33,11,832.38 crore.

The market opened in red on December 22, 2020, overall volumes in futures & options currently stand at 3,78,82,868 contracts with a turnover of Rs. 33,11,832.38 crore.

BSE-listed NBFC Moneyboxx Finance Limited (MBFL) raises debt of Rs 10 crore from BlackSoil Caspian and Ashv Finance. 

AstraZeneca Pharma India Limited informed on Monday that it has been granted permission by Drugs Controller General of India (DCGI) for importing & marketing of Benralizumab 30mg/ml solution for injection (Fasenra™). The medicine helps in treating a severe & rare type of asthma caused mainly in adults.